We are live on ! Find out more
BSX icon

Boston Scientific
BSX

698 hedge funds and large institutions have $49.2B invested in Boston Scientific in 2018 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 235 increasing their positions, 239 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $232M | Put options by funds: $100M

61% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 56

20% more funds holding in top 10

Funds holding in top 10: 15 → 18 (+3)

18% more capital invested

Capital invested by funds: $41.7B → $49.2B (+$7.52B)

4% more funds holding

Funds holding: 671 → 698 (+27)

0.2% less ownership

Funds ownership: 92.63% → 92.42% (-0.2%)

2% less repeat investments, than reductions

Existing positions increased: 235 | Existing positions reduced: 239

Holders
698
Holders Change
+27
Holders Change %
+4.02%
% of All Funds
15.96%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.41%
New
90
Increased
235
Reduced
239
Closed
56
Calls
$232M
Puts
$100M
Net Calls
+$132M
Net Calls Change
+$33.9M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$308M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$301M
3
Allianz Asset Management
Allianz Asset Management
Germany
+$179M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$110M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$105M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$626M
2
Goldman Sachs
Goldman Sachs
New York
-$169M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$127M
4
GA
Geller Advisors
New York
-$90.2M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$89.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$6.36B +$301M +8,617,011 +6%
BlackRock
2
BlackRock
New York
$4.32B +$103M +2,958,437 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.91B +$47.7M +1,367,053 +1%
Capital World Investors
4
Capital World Investors
California
$3.46B -$626M -17,918,061 -17%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$2.44B -$127M -3,640,871 -5%
State Street
6
State Street
Massachusetts
$2.18B +$89.5M +2,562,620 +5%
JP Morgan Chase
7
JP Morgan Chase
New York
$1.81B +$94.4M +2,701,658 +6%
Primecap Management
8
Primecap Management
California
$1.72B -$1.37M -39,356 -0.1%
Janus Henderson Group
9
Janus Henderson Group
United Kingdom
$1.55B -$50.2M -1,437,859 -3%
BG
10
Bollard Group
Massachusetts
$1.29B +$1.98M +56,622 +0.2%
Artisan Partners
11
Artisan Partners
Wisconsin
$956M -$17.7M -507,273 -2%
Capital Research Global Investors
12
Capital Research Global Investors
California
$747M +$308M +8,814,601 +83%
Norges Bank
13
Norges Bank
Norway
$689M +$5.41M +154,754 +0.9%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$626M -$65.9M -1,888,055 -10%
Goldman Sachs
15
Goldman Sachs
New York
$606M -$169M -4,828,750 -23%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$586M +$25.9M +742,095 +5%
Northern Trust
17
Northern Trust
Illinois
$575M -$2.38M -68,010 -0.5%
Aberdeen Group
18
Aberdeen Group
United Kingdom
$466M -$66.4M -1,901,611 -14%
Wells Fargo
19
Wells Fargo
California
$424M -$27.8M -796,346 -7%
Newport Trust Company
20
Newport Trust Company
District of Columbia
$401M -$7.83M -224,245 -2%
Invesco
21
Invesco
Georgia
$366M +$43.3M +1,238,574 +15%
Bank of America
22
Bank of America
North Carolina
$340M -$789K -22,596 -0.3%
Citadel Advisors
23
Citadel Advisors
Florida
$314M +$46.1M +1,318,868 +19%
FAM
24
Fred Alger Management
New York
$311M +$81.4M +2,329,670 +41%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$309M +$79M +2,261,008 +39%
1
2 3 4 5

BSX Hedge Fund Activity: Q3 2018 in Review

698 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2018, worth a combined $49.2B — up 18% from $41.7B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new BSX positions and 56 closed out — a net gain of 34 holders — while 235 added to existing stakes and 239 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $308M. The largest seller was Capital World Investors, cutting an estimated $626M.

  • 698 institutional investors held Boston Scientific (BSX) as of Q3 2018, up from 671 in Q2 2018.
  • Funds reported $49.2B of Boston Scientific stock for Q3 2018, up 18% quarter-over-quarter.
  • 90 funds opened new Boston Scientific positions in Q3 2018 and 56 closed out, a net change of +34 holders.
  • The largest Boston Scientific buyer in Q3 2018 was Capital Research Global Investors, an estimated $308M added.
  • The largest Boston Scientific seller in Q3 2018 was Capital World Investors, an estimated $626M sold.

Based on aggregated 13F filings for Q3 2018.